US Cannabis Market Outpaces Canada as Investment Destination
Cross-border cannabis executives increasingly favor US opportunities over Canadian market saturation and regulatory constraints.
Cannabis industry executives continue shifting focus toward US market opportunities as Canada's legal cannabis sector struggles with oversupply and compressed margins. The contrast between markets has become stark, with US operators generating higher per-gram revenues despite operating under federal prohibition.
Canada's legal cannabis market faces structural challenges that limit growth potential. Provincial distribution bottlenecks, heavy taxation, and persistent black market competition have created margin pressure across the supply chain. Licensed producers trade at fraction of peak valuations, with many consolidating operations or exiting entirely. The market generated CAD $4.7 billion in 2023 sales, but growth rates have decelerated significantly from early legalization years.
US cannabis markets present different dynamics despite federal scheduling complications. State-legal operators achieve premium pricing in limited license jurisdictions, with some markets generating over $300 per ounce wholesale compared to Canada's sub-$150 pricing. Multi-state operators like Curaleaf (CURLF) and Green Thumb Industries (GTBIF) report EBITDA margins exceeding 25% in mature markets, substantially higher than Canadian counterparts.
Regulatory momentum favors US expansion strategies. The Biden administration's rescheduling initiative could eliminate 280E tax penalties that currently burden operators, potentially adding 20-40% to bottom lines. Meanwhile, Canada's regulatory framework remains static, with no major policy catalysts expected to revive growth momentum.
Cross-border capital allocation reflects this opportunity gap. Canadian cannabis companies increasingly pursue US market entry through licensing deals and management agreements, while US operators show little interest in northern expansion. The divergence suggests fundamental market maturity differences, with US cannabis still in early monetization phases while Canada approaches commodity-level dynamics. This trend will likely accelerate as more states legalize and federal barriers diminish.